Sabra Health Care REIT, Inc. (SBRA)
- Previous Close
17.85 - Open
17.80 - Bid 12.61 x 200
- Ask 17.67 x 100
- Day's Range
17.55 - 17.85 - 52 Week Range
13.87 - 20.03 - Volume
558,579 - Avg. Volume
2,516,260 - Market Cap (intraday)
4.2B - Beta (5Y Monthly) 0.91
- PE Ratio (TTM)
32.69 - EPS (TTM)
0.54 - Earnings Date May 5, 2025
- Forward Dividend & Yield 1.20 (6.72%)
- Ex-Dividend Date Feb 14, 2025
- 1y Target Est
19.50
As of September 30, 2024, Sabra's investment portfolio included 373 real estate properties held for investment (consisting of (i) 233 skilled nursing/transitional care facilities, (ii) 39 senior housing communities (senior housing - leased), (iii) 68 senior housing communities operated by third-party property managers pursuant to property management agreements (senior housing - managed), (iv) 18 behavioral health facilities and (v) 15 specialty hospitals and other facilities), 14 investments in loans receivable (consisting of three mortgage loans and 11 other loans), five preferred equity investments and two investments in unconsolidated joint ventures. As of September 30, 2024, Sabra's real estate properties held for investment included 37,793 beds/units, spread across the United States and Canada.
www.sabrahealth.com50
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: SBRA
View More
Performance Overview: SBRA
Trailing total returns as of 5/1/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SBRA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SBRA
View MoreValuation Measures
Market Cap
4.25B
Enterprise Value
6.63B
Trailing P/E
33.06
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
5.99
Price/Book (mrq)
1.55
Enterprise Value/Revenue
9.43
Enterprise Value/EBITDA
16.07
Financial Highlights
Profitability and Income Statement
Profit Margin
18.03%
Return on Assets (ttm)
3.00%
Return on Equity (ttm)
4.57%
Revenue (ttm)
702.64M
Net Income Avi to Common (ttm)
126.71M
Diluted EPS (ttm)
0.54
Balance Sheet and Cash Flow
Total Cash (mrq)
81.94M
Total Debt/Equity (mrq)
88.50%
Levered Free Cash Flow (ttm)
250.41M
Research Analysis: SBRA
View MoreResearch Reports: SBRA
View MoreWhat does Argus have to say about SBRA?
SABRA HEALTH CARE REIT INC has an Investment Rating of BUY; a target price of $19.000000; an Industry Subrating of High; a Management Subrating of High; a Safety Subrating of High; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice TargetWhat does Argus have to say about SBRA?
SABRA HEALTH CARE REIT INC has an Investment Rating of BUY; a target price of $19.000000; an Industry Subrating of High; a Management Subrating of High; a Safety Subrating of High; a Financial Strength Subrating of High; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice TargetRaising target price to $19.00
SABRA HEALTH CARE REIT INC has an Investment Rating of BUY; a target price of $19.000000; an Industry Subrating of High; a Management Subrating of High; a Safety Subrating of High; a Financial Strength Subrating of High; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice TargetLowering target price to $18.00
SABRA HEALTH CARE REIT INC has an Investment Rating of BUY; a target price of $18.000000; an Industry Subrating of High; a Management Subrating of High; a Safety Subrating of High; a Financial Strength Subrating of Medium; a Growth Subrating of High; and a Value Subrating of Medium.
RatingPrice Target